5 takeaways from Emergent BioSolutions' congressional testimony

Two top executives at Emergent BioSolutions, the manufacturing plant that had to toss 15 million doses of Johnson & Johnson's COVID-19 vaccine after mixing it up with ingredients of AstraZeneca's vaccine, testified before Congress May 19 on the company's COVID-19 contracts and manufacturing processes.